biotech industry (their customers) has struggled with low valuations on new therapeutics and little ability to raise money. some green shoots with some deal making evident this year.
the biggest challenge is tax-loss selling season coming up. there is probably lower prices to come mid June for those on the sidelines such as myself.
Ann: Trajan May 2024 Market Update, page-5
Add TRJ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.01 |
Change
0.010(1.00%) |
Mkt cap ! $153.7M | |||
| Open | High | Low | Value | Volume |
| $1.00 | $1.01 | $1.00 | $48.04K | 47.84K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6393 | $1.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.01 | 14687 | 1 |
View Market Depth
| Last trade - 15.44pm 05/07/2024 (20 minute delay) ? |
| TRJ (ASX) Chart |